Published in PLoS One on July 09, 2014
Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer. Front Genet (2014) 0.87
Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front Genet (2015) 0.85
Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1. Int J Clin Exp Pathol (2015) 0.84
Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Int J Clin Exp Pathol (2015) 0.82
Long Noncoding RNA-Sox2OT Knockdown Alleviates Diabetes Mellitus-Induced Retinal Ganglion Cell (RGC) injury. Cell Mol Neurobiol (2016) 0.77
Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis. Oncotarget (2016) 0.75
Copy number loss of variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2015) 0.75
Differential expression of lncRNAs during the HIV replication cycle: an underestimated layer in the HIV-host interplay. Sci Rep (2016) 0.75
LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer. Am J Transl Res (2016) 0.75
Insights into long noncoding RNAs of naked mole rat (Heterocephalus glaber) and their potential association with cancer resistance. Epigenetics Chromatin (2016) 0.75
Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells. PLoS One (2016) 0.75
ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells. Biol Direct (2016) 0.75
The Effect of MicroRNA-375 Overexpression, an Inhibitor of Helicobacter pylori-Induced Carcinogenesis, on lncRNA SOX2OT. Jundishapur J Microbiol (2016) 0.75
Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma. PLoS One (2016) 0.75
Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer. Curr Pathobiol Rep (2017) 0.75
Expression of a SOX1 overlapping transcript in neural differentiation and cancer models. Cell Mol Life Sci (2017) 0.75
Changes in the Coding and Non-coding Transcriptome and DNA Methylome that Define the Schwann Cell Repair Phenotype after Nerve Injury. Cell Rep (2017) 0.75
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers. Front Oncol (2017) 0.75
Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis. PLoS One (2017) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
The sequence of the human genome. Science (2001) 101.55
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science (2007) 18.59
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29
Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc (2006) 8.42
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res (2008) 7.65
Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet (2005) 5.07
Mutations in SOX2 cause anophthalmia. Nat Genet (2003) 5.03
Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol (2000) 3.90
Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet (2000) 3.82
The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem (2008) 3.01
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res (2008) 2.96
Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene (2011) 2.73
Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res (2002) 2.49
Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev (2002) 2.24
Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res (2005) 2.18
Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer (2008) 2.11
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol (2007) 2.09
SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA (2011) 2.03
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A (2000) 2.02
Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells. Cancer Biol Ther (2011) 1.86
Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol (2004) 1.79
MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity. Cancer Biol Ther (2010) 1.77
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer (2011) 1.74
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene (2011) 1.66
Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells. Genes Dev (2004) 1.63
mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc Natl Acad Sci U S A (2009) 1.63
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One (2011) 1.57
Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci U S A (2005) 1.56
Complex architecture and regulated expression of the Sox2ot locus during vertebrate development. RNA (2009) 1.44
Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res (2007) 1.37
Effects of estrogen on the proportion of stem cells in the breast. Breast Cancer Res Treat (2010) 1.31
The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials (2011) 1.30
Sox2 promotes tamoxifen resistance in breast cancer cells. EMBO Mol Med (2014) 1.30
SOX2 contributes to melanoma cell invasion. Lab Invest (2011) 1.21
The Sox-2 regulatory regions display their activities in two distinct types of multipotent stem cells. Mol Cell Biol (2004) 1.13
Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells (2014) 1.11
Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. Prostate (2000) 1.09
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway. Cell Cycle (2013) 1.08
Constructing the landscape of the mammalian transcriptome. J Exp Biol (2007) 1.03
Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage. Mol Cell Biol (2011) 1.00
Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity. Cell Signal (2012) 0.95
Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells. PLoS One (2012) 0.92
In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PLoS One (2013) 0.92
Identification of expressed and conserved human noncoding RNAs. RNA (2013) 0.89
Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells. Invest New Drugs (2011) 0.86
Evidence for the existence of triple-negative variants in the MCF-7 breast cancer cell population. Biomed Res Int (2014) 0.82
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov (2014) 1.10
Evidence for the existence of triple-negative variants in the MCF-7 breast cancer cell population. Biomed Res Int (2014) 0.82
Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines. PLoS One (2014) 0.81
Retrotransposon hypomethylation in melanoma and expression of a placenta-specific gene. PLoS One (2014) 0.75
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers. Front Oncol (2017) 0.75